 |
|
raltitrexed
A quinazoline folate analogue with antineoplastic activity. After transport into cells via the reduced folate carrier, raltitrexed undergoes intracellular polyglutamation and blocks the folate-binding site of thymidylate synthase, thereby inhibiting tetrahydrofolate activity and DNA replication and repair and resulting in cytotoxicity. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| US brand name: | | Tomudex | | | | Abbreviation: | | TDX | | | | Code names: | | D1694
ICI-D1694
ZD1694 | | | | Chemical structure names: | | - N-(5-[N-(3,4-dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino]-2-thenoyl)-L-glutamic acid
- N-[[5-[[(1,4-dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl]methylamino]-2-thienyl]carbonyl]-L-glutamic acid
| | |
|
|
